Central Laboratory, Changchun Normal University, Changchun 130032, China.
College of Chemistry, Jilin University, Changchun 130021, Jilin, China.
Fitoterapia. 2024 Jun;175:105856. doi: 10.1016/j.fitote.2024.105856. Epub 2024 Feb 12.
Poria cocos (Schw.) Wolf (P. cocos) has been widely used as medical plant in East Asia with remarkable anti-Alzheimer's disease (anti-AD) activity. However, the underlying mechanisms are still confused. In this study, based on the β-Amyloid deposition hypothesis of AD, an integrated analysis was conducted to screen and separation 5-lipoxygenase (5-LOX) inhibitors from triterpenoids of P. cocos and investigate the anti-AD mechanisms, containing bioaffinity ultrafiltration UPLC-Q-Exactive, molecular docking, and multiple complex networks. Five triterpenoids were identified as potential 5-LOX inhibitors, including Tumulosic acid, Polyporenic acid C, 3-Epi-dehydrotumulosic acid, Pachymic acid and Dehydrotrametenolic acid. Five potential 5-LOX inhibitors were screened by ultrafiltration affinity assay in P. cocos. The molecular docking simulation results are consistent with the ultrafiltration experimental results, which further verifies the accuracy of the experiment. The commercial 5-LOX inhibitor that Zileuton was used as a positive control to evaluate the inhibitory effect of active ingredients on 5-LOX. Subsequently, the established separation method allowed the five active ingredients (Pachymic acid, 3-Epi-dehydrotumulosic acid, Dehydrotrametenolic acid, Tumulosic acid and Polyporenic acid C) with high purity to be isolated. Targeting network pharmacology analysis showed that five active ingredients correspond to a total of 286 targets. Kyoto encyclopedia of genes and genomes (KEGG) enrichment analysis found that target cells were mainly enriched in Pathways in cancer, Lipid and atherosclerosis. Our results indicate that P. cocos extract has the potential to be used in the prevention and treatment of neurodegenerative diseases. This will help elucidate the mechanisms of action of various medicinal plants at the molecular level and provide more opportunities for the discovery and development of new potential treatments from health food resources.
药用真菌茯苓(Schw.)Wolf(P. cocos)在东亚被广泛用作药用植物,具有显著的抗阿尔茨海默病(anti-AD)活性。然而,其作用机制仍不清楚。在这项研究中,基于 AD 的β-淀粉样蛋白沉积假说,我们进行了综合分析,从茯苓三萜中筛选和分离 5-脂氧合酶(5-LOX)抑制剂,并研究其抗 AD 机制,包括生物亲和超滤 UPLC-Q-Exactive、分子对接和多个复杂网络。鉴定了 5 种潜在的 5-LOX 抑制剂,包括 Tumulosic acid、Polyporenic acid C、3-Epi-dehydrotumulosic acid、Pachymic acid 和 Dehydrotrametenolic acid。通过超滤亲和实验从茯苓中筛选出 5 种潜在的 5-LOX 抑制剂。分子对接模拟结果与超滤实验结果一致,进一步验证了实验的准确性。以 Zileuton 为阳性对照,评价活性成分对 5-LOX 的抑制作用,建立分离方法,可使 5 种活性成分(Pachymic acid、3-Epi-dehydrotumulosic acid、Dehydrotrametenolic acid、Tumulosic acid 和 Polyporenic acid C)高纯度分离。基于网络药理学的靶点分析表明,5 种活性成分共对应 286 个靶点。京都基因与基因组百科全书(KEGG)富集分析发现,靶细胞主要富集在癌症、脂质和动脉粥样硬化途径中。我们的研究结果表明,茯苓提取物具有预防和治疗神经退行性疾病的潜力。这将有助于从分子水平阐明各种药用植物的作用机制,并为从保健品资源中发现和开发新的潜在治疗方法提供更多机会。